KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Jul 05, 2017 $11.60 $12.40 $11.30 $11.90 2 107 838
Jul 03, 2017 $11.45 $11.80 $11.20 $11.45 924 892
Jun 30, 2017 $12.00 $12.10 $11.35 $11.45 2 412 045
Jun 29, 2017 $12.15 $12.25 $11.15 $12.00 4 958 766
Jun 28, 2017 $13.70 $14.00 $12.10 $12.15 6 360 737
Jun 27, 2017 $14.50 $15.90 $13.45 $13.48 13 337 439
Jun 26, 2017 $19.80 $19.97 $18.25 $18.70 1 009 359
Jun 23, 2017 $19.30 $19.75 $18.77 $19.70 1 377 498
Jun 22, 2017 $19.15 $19.80 $18.85 $19.40 1 000 856
Jun 21, 2017 $19.30 $19.75 $18.35 $19.00 1 122 949
Jun 20, 2017 $18.85 $20.00 $18.70 $19.10 1 543 052
Jun 19, 2017 $17.50 $18.95 $17.50 $18.80 975 276
Jun 16, 2017 $17.35 $18.00 $17.20 $17.50 939 794
Jun 15, 2017 $16.75 $17.75 $16.70 $17.65 694 665
Jun 14, 2017 $17.25 $17.50 $16.65 $17.05 491 285
Jun 13, 2017 $16.40 $17.20 $16.30 $17.15 826 830
Jun 12, 2017 $16.85 $17.25 $16.35 $16.40 653 916
Jun 09, 2017 $16.75 $17.25 $16.40 $16.80 856 472
Jun 08, 2017 $16.30 $16.75 $15.65 $16.60 456 685
Jun 07, 2017 $16.75 $16.85 $16.05 $16.35 352 619
Jun 06, 2017 $16.60 $17.00 $16.25 $16.70 410 848
Jun 05, 2017 $17.55 $17.92 $16.55 $16.65 946 735
Jun 02, 2017 $17.00 $18.00 $16.38 $17.50 1 376 712
Jun 01, 2017 $15.55 $17.35 $15.15 $17.00 1 771 434
May 31, 2017 $16.15 $16.35 $15.10 $15.40 731 856
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT